{"id":74,"date":"2019-03-20T17:54:36","date_gmt":"2019-03-20T17:54:36","guid":{"rendered":"https:\/\/www.libertymanagement.us\/fda-support\/?p=74"},"modified":"2019-04-11T15:54:22","modified_gmt":"2019-04-11T15:54:22","slug":"fda-policy-on-cosmetic-recalls","status":"publish","type":"post","link":"https:\/\/www.libertymanagement.us\/fda-support\/2019\/03\/20\/fda-policy-on-cosmetic-recalls\/","title":{"rendered":"FDA policy on Cosmetic recalls"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong><em>What is a recall?<\/em><\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A recall is when a company withdraws its defective or contaminated products, from the market, that FDA considers to be in violation of laws, and that are likely to invoke a legal action such as seizure.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong><em>Role&nbsp;of&nbsp;FDA<\/em><\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Under FD&amp;C Act, FDA does not have the authority to order a recall of <a href=\"https:\/\/www.fdahelp.us\/cosmetics.html\" target=\"_blank\" rel=\"noreferrer noopener\" aria-label=\"cosmetic (opens in a new tab)\">cosmetic<\/a>, but it may request a firm to do so. FDA is actively involved in:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Monitoring\nthe progress of a recall by conducting own audit checks at wholesale or retail customers\nto verify the recall\u2019s effectiveness.<\/li><li>Evaluating\nthe product under recall and assigning a classification to indicate degree of\nhazard posed by the product.<\/li><li>Ensure\na public notification is issued either by itself or by the firm.<\/li><li>Develop\nrecall strategy or review one developed by the firm.<\/li><li>Ensure\nthat the recalled products are destroyed or reconditioned suitably.<\/li><\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">FDA\nclassifies recalls under three categories:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Class\nI: for situations where products may cause serious health hazards or death<\/li><li>Class\nII: for situations where the product may cause temporary or medically\nreversible health consequence<\/li><li>Class\nIII: for situations where product is not likely to cause adverse health\nconsequences<\/li><\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><em><strong>Role of a Cosmetic Firm<\/strong><\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">When\na product is found to be in violation, a cosmetic firm must:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Notify\nits customer <\/li><li>Notify\nFDA<\/li><li>Submit\nperiodic recall status reports to appropriate FDA district office<\/li><li>Issue\na public notification, if necessary<\/li><li>Destroy\nthe products or act to bring them into compliance.<\/li><\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">To\nminimize the damage caused by a product recall, a cosmetic firm must:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Prevent\nproduct adulteration and misbranding<\/li><li>Maintain\na contingency plan in case a recall does happen<\/li><li>Assign\nproduction lot numbers to track the possible affected products<\/li><li>maintain\nadequate records to determine the location of products. <\/li><\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">FDA\nhas detailed regulatory procedures regarding what to expect if an FDA\ninvestigator conducts an inspection related to a recall. The objective of such\ninspection is to identify the root cause for the recall and to ensure that the\nfirm has taken measures to prevent the reoccurrence of such problems and their\ncause. FDA takes the following steps:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Issue Notice of Inspection<\/li><li>Discuss problem with management<\/li><li>Investigate all circumstances which may affect\nproducts deficiency<\/li><li>Review records, logs for violative lots<\/li><li>Review firm\u2019s quality control data<\/li><li>Determine if any actions are taken or planned\nto prevent similar occurrences.<\/li><li>Determine what actions are taken or planned\nfor products still in commerce.<\/li><\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><em><a href=\"https:\/\/www.fdahelp.us\/\" target=\"_blank\" rel=\"noreferrer noopener\" aria-label=\" (opens in a new tab)\">Liberty Management Group LTD<\/a><\/em><strong><em>&nbsp; is one of the leading FDA consulting groups in the USA. LMG provides assistance registrations, labels, and many more FDA regulations.<\/em><\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Namrata\nGusain<\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>FDA\nRegulatory Consultant<\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>support@libertymanagement.us<\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"http:\/\/www.fdahelp.us\" target=\"_blank\" rel=\"noreferrer noopener\" aria-label=\" (opens in a new tab)\">http:\/\/www.fdahelp.us<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Published on March 20, 2019<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>What is a recall? A recall is when a company withdraws its defective or contaminated products, from the market, that FDA considers to be in violation of laws, and that are likely to invoke a legal action such as seizure. Role&nbsp;of&nbsp;FDA Under FD&amp;C Act, FDA does not have the authority to order a recall of &hellip; <a href=\"https:\/\/www.libertymanagement.us\/fda-support\/2019\/03\/20\/fda-policy-on-cosmetic-recalls\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;FDA policy on Cosmetic recalls&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[33,18,2],"class_list":["post-74","post","type-post","status-publish","format-standard","hentry","category-cosmetics-regulations","tag-cosmetic-recalls","tag-fda-inspection","tag-fda-registration"],"_links":{"self":[{"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/posts\/74","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/comments?post=74"}],"version-history":[{"count":7,"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/posts\/74\/revisions"}],"predecessor-version":[{"id":90,"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/posts\/74\/revisions\/90"}],"wp:attachment":[{"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/media?parent=74"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/categories?post=74"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/tags?post=74"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}